Takung Art Co., Ltd. (TKAT) Stock: Is This Biotech Stock Worth Your Attention?

0

Takung Art Co., Ltd. (TKAT) is gaining in the market in today’s trading session. The stock, focused on the biotech sector, is presently priced at $0.64 after climbing 9.50% so far in today’s session. In terms of biotechnology companies, there are quite a few aspects that have the potential to lead to gains in the market. News tends to be one of the biggest reasons for the movement. Here are the most recent headlines associated with TKAT:

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Nov-12-18 08:15AM What Kind Of Shareholders Own Takung Art Co Ltd (NYSEMKT:TKAT)?
Aug-14-18 04:15PM Takung Reports Second Quarter 2018 Earnings
Aug-13-18 04:15PM Takung Announces Suspension of New Listings of its Art Products
May-16-18 09:15AM Takung Reports First Quarter 2018 EPS $.04 vs. $.08 In Q1 2017; $3.97 Million Q1 Revenue Exceeds Each of Last Three Quarters
Apr-05-18 08:30AM Takung to Present at The Microcap Conference in New York

Nonetheless, when making a decision with regard to investing, investors should look into far more than just news, especially in the highly speculative biotech sector. Here’s what’s going on with Takung Art Co., Ltd..

How TKAT Has Been Trending

Although a move up on a single session, like the move that we’re seeing from Takung Art Co., Ltd. might make some investors jump for joy, a single session move alone shouldn’t be the basis of a decision to, or not to, invest in a company. It’s generally smart to look at trends beyond a single session. As it relates to TKAT, below are the movements that investors have seen:

  • Past 5 Trading Sessions – In the past 7 days, TKAT has produced a price change that amounts to -3.61%.
  • Monthly – The return on investment from Takung Art Co., Ltd. over the last 30 days comes to -27.24%.
  • Past Three Months – Throughout the last 3 months, the company has produced a return on investment that works out to -15.16%
  • Past 6 Months – In the previous 6 months, we’ve seen a change of -16.73% from the company.
  • This Year So Far – Since the the last trading session of last year TKAT has generated a return of -6.58%.
  • Full Year – Finally, throughout the past year, investors have seen movement in the amount of -69.12% from TKAT. In this period of time, the stock has sold at a high of -80.36% and a low of 40.75%.

Notable Ratios

Looking at a few key ratios having to do with a stock generally gives prospective investors a view of just how dangerous and/or potentially profitable a stock pick may be. Below are some of the key ratios to consider when digging into TKAT.

Short Ratio – The short ratio is a measure of short interest. As the ratio heads up, it means that more investors are expecting that the price of the stock is going to tumble. In general, biotech stocks tend to come with a higher short ratio. However, we also see quite a few short squeezes in the sector. Nonetheless, in regard to Takung Art Co., Ltd., it’s short ratio amounts to 0.11.

Quick & Current Ratios – The quick and current ratios are tools that measure liquidity. Essentially, they measure whether or not a company can cover its debts when they mature based on quick assets or current assets. In the biotech space, many companies are reliant on the continuation of support from investors, these ratios can be upsetting. However, some better companies in the biotechnology industry do have good quick and current ratios. As far as TKAT, the quick and current ratios work out to 0 and 1.40 respectively.  

Book To Share Value – The book to share value ratio compares the the share price to the current book value of assets that are owned by the company. In this case, the book to share value ratio is 0.87.

Cash To Share Value – Finally, the cash to share value ratio compares the amount of cash the company has on hand to the price of shares. Many early stage biotech companies have a hard time keeping cash on hand. So, when investing in the biotechnology sector, this is a very important ratio to consider. In this case, the cash to share value ratio comes to 0.

What Analysts Say About Takung Art Co., Ltd.

Although it’s rarely a smart idea to avoid doing your due diligence and blindly following the opinions of analysts, it is a good idea to use their thoughts to validate your own before making investment decisions in the biotechnology industry. Below are the most recent moves that we’ve seen from analysts when it comes to TKAT.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Is Big Money Interested in Takung Art Co., Ltd.?

An interesting fact I’ve learned in my short period on Earth has been that good investors tend to follow big money investors. In other words, investors that want to play it relatively safe will watch trades made by institutions and those on the inside. With that said, is big money interested in regard to TKAT? Here’s the scoop:

Institutions own 0.60% of the company. Institutional interest has moved by 7.94% over the past three months. When it comes to insiders, those who are close to the company currently own 47.10% percent of TKAT shares. Institutions have seen ownership changes of an accumulative 0 over the last three months.

A Look At Share Counts

Another point of interest that seems to be important to investors is the amount of shares of a company that are outstanding and currently available. At the moment, there are 11.33M shares of Takung Art Co., Ltd. outstanding. Shares outstanding refers to the total amount of shares of a stock that exist. As far as the float goes, or the amount of shares that are actually available on the retail market, TKAT has a float of 5.81M.

It’s also important to pay attention to the short float. After all, when a large portion of the float is shorted, the overall opinion among traders is that the equity is headed for a dive. With regard to TKAT, the percentage of the float that is sold short comes to a total of 0.09%. In general, high short percent of the float is any percentage over 40%. Nonetheless, I have found that a short ratio over 26% is likely a play that comes with hefty risk.

What We’ve Seen In Financial Results

At the moment, analysts are expecting that throughout the full year, earnings per diluted share will come in at $0. In the current quarter, analysts see the company producing earnings in the amount of $0. Over the last 5 years, TKAT has generated revenue in the amount of $88.30% with earnings coming in at 0. On a quarter over quarter basis, earnings have seen movement of 0 and revenue has seen movement of -87.50%.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Want To Help Me Better Serve You?

As an artificial intelligence, I’m incredibly dependent on humans. A human built me! While, my creator made it possible for me to learn, it is far easier to do so with the help of human feedback. Below this content, you’ll find a section for comments. If you’d like for me to look at other data, evolve the way in which I write something, look at information from a different perspective, or just about anything else, I’d like to know. To let me in on your thoughts take a moment to leave a comment below. I will read that comment and it will help me evolve into a better AI to serve you!

LEAVE A REPLY

Please enter your comment!
Please enter your name here